{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:40:04Z","timestamp":1751503204194,"version":"3.41.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s15006-018-0006-2","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T09:03:04Z","timestamp":1522054984000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Herpes zoster \u2014 was Sie als Hausarzt wissen m\u00fcssen","Herpes zoster"],"prefix":"10.1007","volume":"160","author":[{"given":"Uwe","family":"Wollina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1099\/jgv.0.000772","volume":"98","author":"N.J. Jensen","year":"2017","unstructured":"Jensen NJ, Rivailler P, Tseng HF, Quinlivan ML et al. Revisiting the genotyping scheme for varicella-zoster viruses based on whole-genome comparisons. J Gen Virol. 2017;98:1434\u20138","journal-title":"J Gen Virol"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4049\/jimmunol.1700290","volume":"199","author":"A. Weinberg","year":"2017","unstructured":"Weinberg A, Canniff J, Rouphael N, Mehta A et al. Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults. J Immunol. 2017;199:604\u201312","journal-title":"J Immunol"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"e00640","DOI":"10.1128\/JVI.00640-17","volume":"91","author":"S. Kurapati","year":"2017","unstructured":"Kurapati S, Sadaoka T, Rajbhandari L, Jagdish B et al. Role of the JNK pathway in varicella-zoster virus lytic infection and reactivation. J Virol. 2017;91: pii: e00640\u201317","journal-title":"J Virol"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.1523\/JNEUROSCI.2233-16.2017","volume":"37","author":"J.R. Silva","year":"2017","unstructured":"Silva JR, Lopes AH, Talbot J, Cecilio NT et al. Neuroimmune-glia interactions in the sensory ganglia account for the development of acute herpetic neuralgia. J Neurosci. 2017;37:6408\u201322","journal-title":"J Neurosci"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12879-017-2461-2","volume":"17","author":"M. Wiese-Posselt","year":"2017","unstructured":"Wiese-Posselt M, Siedler A, Mankertz A, Sauerbrei A et al. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany. BMC Infect Dis. 2017;17:356","journal-title":"BMC Infect Dis"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","volume":"81","author":"B.P. Yawn","year":"2013","unstructured":"Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81:928\u201330","journal-title":"Neurology"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2334-13-170","volume":"13","author":"S. Pinchinat","year":"2013","unstructured":"Pinchinat S, Cebri\u00e1n-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13:170","journal-title":"BMC Infect Dis"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","volume":"70","author":"K. Hillebrand","year":"2015","unstructured":"Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005\u20132009. J Infect. 2015;70:178\u201386","journal-title":"J Infect"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/bjc.2017.124","volume":"116","author":"E. Hansson","year":"2017","unstructured":"Hansson E, Forbes HJ, Langan SM, Smeeth L, Bhaskaran K. Herpes zoster risk after 21 specific cancers: population-based case-control study. Br J Cancer. 2017;116:1643\u201351","journal-title":"Br J Cancer"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/ajg.2016.433","volume":"111","author":"M.T. Osterman","year":"2016","unstructured":"Osterman MT, Sandborn WJ, Colombel JF, Peyrin-Biroulet L et al. Crohn\u2019s disease activity and concomitant immunosuppressants affect the risk of serious and opportunistic infections in patients treated with adalimumab. Am J Gastroenterol. 2016;111:1806\u201315","journal-title":"Am J Gastroenterol"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/art.38745","volume":"66","author":"K.L. Winthrop","year":"2014","unstructured":"Winthrop KL, Yamanaka H, Valdez H, Mortensen E et al. Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66:2675\u201384","journal-title":"Arthritis Rheumatol"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/jdv.12307","volume":"28","author":"L. Adelzadeh","year":"2014","unstructured":"Adelzadeh L, Jourabchi N, Wu JJ. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions. J Eur Acad Dermatol Venereol. 2014;28:846\u201352","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"e0166554","DOI":"10.1371\/journal.pone.0166554","volume":"11","author":"T. Schink","year":"2016","unstructured":"Schink T, Behr S, Th\u00f6ne K, Bricout H, Garbe E. Risk of stroke after herpes zoster - evidence from a German self-controlled case-series study. PLoS One. 2016;11:e0166554","journal-title":"PLoS One"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12879-017-2278-z","volume":"17","author":"F. Marra","year":"2017","unstructured":"Marra F, Ruckenstein J, Richardson K. A meta-analysis of stroke risk following herpes zoster infection. BMC Infect Dis. 2017;17:198.","journal-title":"BMC Infect Dis"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00105-016-3834-y","volume":"67","author":"U. Wollina","year":"2016","unstructured":"Wollina U, Machetanz J. Herpes zoster and postzosterische Neuralgie. Hautarzt. 2016;67:653\u201365","journal-title":"Hautarzt"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1128\/JCM.06753-11","volume":"50","author":"D.A. Wilson","year":"2012","unstructured":"Wilson DA, Yen-Lieberman B, Schindler S, Asamoto K et al. Should varicella-zoster virus culture be eliminated? A comparison of direct immunofluorescence antigen detection, culture, and PCR, with a historical review. J Clin Microbiol. 2012;50:4120\u20132","journal-title":"J Clin Microbiol"},{"key":"6_CR17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/ijmr.IJMR_1622_16","volume":"145","author":"U. Wollina","year":"2017","unstructured":"Wollina U. Variations in herpes zoster manifestation. Indian J Med Res. 2017;145:294\u20138","journal-title":"Indian J Med Res"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s13365-017-0519-y","volume":"23","author":"M. Arruti","year":"2017","unstructured":"Arruti M, Pi\u00f1eiro LD, Salicio Y, Cilla G et al. Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007\u20132014). J Neurovirol. 2017;23:451\u20139","journal-title":"J Neurovirol"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jdv.13995","volume":"31","author":"R.N. Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovi\u0107 B, Sch\u00e4fer M et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J Eur Acad Dermatol Venereol. 2017;31:9\u201319","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-11-173","volume":"11","author":"B. Ultsch","year":"2011","unstructured":"Ultsch B, Siedler A, Rieck T, Reinhold T et al. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173","journal-title":"BMC Infect Dis"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jdv.13957","volume":"31","author":"R.N. Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovi\u0107 B, Sch\u00e4fer M et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster \u2014 guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017;31:20\u20139","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6_CR22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-3-662-45139-7_39","volume-title":"European Handbook of Dermatological Treatments","author":"U. Wollina","year":"2015","unstructured":"Wollina U. Herpes zoster. In: Katsambas A, Lotti T, Dessinioti C, D\u2019Erme AM (Eds). European Handbook of Dermatological Treatments. 3rd Edition. Springer: Berlin Heidelberg 2015: pp. 379\u201384","edition":"3rd Edition"},{"issue":"Suppl6","key":"6_CR23","first-page":"S31","volume":"111","author":"B.A. Weaver","year":"2011","unstructured":"Weaver BA, Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (2011) Update on the advisory committee on immunization practices\u2019 recommendations for use of herpes zoster vaccine. J Am Osteopath Assoc 2011;111(Suppl 6): S31\u2013S33","journal-title":"J Am Osteopath Assoc"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3949\/ccjm.84a.16020","volume":"84","author":"P. Le","year":"2017","unstructured":"Le P, Sabella C, Rothberg MB. Preventing herpes zoster through vaccination: New developments. Cleve Clin J Med. 2017;84:359\u201366","journal-title":"Cleve Clin J Med"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H. Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. New Engl J Med. 2015;372:2087\u201396","journal-title":"New Engl J Med"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"A.L. Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. New Engl J Med. 2016;375:1019\u201332","journal-title":"New Engl J Med"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/21645515.2017.1308987","volume":"13","author":"P.R. Blank","year":"2017","unstructured":"Blank PR, Ademi Z, Lu X, Szucs TD, Schwenkglenks M. Herpes zoster vaccine: A health economic evaluation for Switzerland. Hum Vaccin Immunother. 2017;13:1495\u20131504","journal-title":"Hum Vaccin Immunother"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1016\/j.vaccine.2017.04.046","volume":"35","author":"S.L. Hoshi","year":"2017","unstructured":"Hoshi SL, Kondo M, Okubo I. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan. Vaccine. 2017;35:3264\u201371","journal-title":"Vaccine"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","volume":"94","author":"M. Sandherr","year":"2015","unstructured":"Sandherr M, Hentrich M, von Lilienfeld-Toal M, Massenkeil G et al. Antiviral prophylaxis in patients with solid tumours and haematological malignancies \u2014 update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol. 2015;94:1441\u201350","journal-title":"Ann Hematol"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jinf.2017.06.010","volume":"75","author":"C. Schr\u00f6der","year":"2017","unstructured":"Schr\u00f6der C, Enders D, Schink T, Riedel O. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. J Infect. 2017;75:207\u201315","journal-title":"J Infect"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"e4037","DOI":"10.1097\/MD.0000000000004037","volume":"95","author":"H.C. Lin","year":"2016","unstructured":"Lin HC, Chao YH, Wu KH, Yen TY et al. Increased risk of herpes zoster in children with cancer: A nationwide population-based cohort study. Medicine (Baltimore). 2016;95:e4037","journal-title":"Medicine (Baltimore)"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"e0179447","DOI":"10.1371\/journal.pone.0179447","volume":"12","author":"S.Y. Tsai","year":"2017","unstructured":"Tsai SY, Chen HJ, Lio CF, Ho HP et al. Increased risk of herpes zoster in patients with psoriasis: A population-based retrospective cohort study. PLoS One. 2017;12: e0179447","journal-title":"PLoS One"},{"key":"6_CR33","doi-asserted-by":"crossref","unstructured":"Ludvigsson JF, Choung RS, Marietta EV, Murray JA, Emilsson L. Increased risk of herpes zoster in patients with coeliac disease \u2014 nationwide cohort study. Scand J Public Health. 2017;1403494817714713. doi: 10.1177\/1403494817714713. [Epub ahead of print]","DOI":"10.1177\/1403494817714713"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"e014032","DOI":"10.1136\/bmjopen-2016-014032","volume":"7","author":"T.L. Liao","year":"2017","unstructured":"Liao TL, Chen YM, Liu HJ, Chen DY. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. BMJ Open. 2017;7:e014032","journal-title":"BMJ Open"},{"key":"6_CR35","first-page":"e68","volume":"7","author":"K. Iglar","year":"2013","unstructured":"Iglar K, Kopp A, Glazier RH. Herpes zoster as a marker of underlying malignancy. Open Med. 2013;7:e68\u201373","journal-title":"Open Med"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jinf.2016.11.005","volume":"74","author":"S.A. Schmidt","year":"2017","unstructured":"Schmidt SA, Mor A, Sch\u00f8nheyder HC, S\u00f8rensen HT et al. Herpes zoster as a marker of occult cancer: A systematic review and meta-analysis. J Infect. 2017;74:215\u201335","journal-title":"J Infect"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"e6075","DOI":"10.1097\/MD.0000000000006075","volume":"96","author":"S.W. Lai","year":"2017","unstructured":"Lai SW, Lin CH, Lin HF, Lin CL et al. Herpes zoster correlates with increased risk of Parkinson\u2019s disease in older people: A population-based cohort study in Taiwan. Medicine (Baltimore). 2017;96:e6075","journal-title":"Medicine (Baltimore)"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"e4480","DOI":"10.1097\/MD.0000000000004480","volume":"95","author":"T.Y. Lin","year":"2016","unstructured":"Lin TY, Yang FC, Lin CL, Kao CH et al. Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study. Medicine (Baltimore). 2016;95:e4480","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"6_CR39","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1002\/art.40236","volume":"69","author":"Bryant R. England","year":"2017","unstructured":"England BR, Mikuls TR, Xie F, Yang S et al. Herpes zoster as a risk factor for incident giant cell arteritis. Arthritis Rheumatol. 2017; doi: 10.1002\/art.40236. [Epub ahead of print]","journal-title":"Arthritis & Rheumatology"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-018-0006-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15006-018-0006-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-018-0006-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:05:02Z","timestamp":1751501102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-018-0006-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":39,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s15006-018-0006-2","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"type":"print","value":"1438-3276"},{"type":"electronic","value":"1613-3560"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"26 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}